Ascopiave S.p.A.
ASCOF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $701 | $945 | $975 | $919 |
| - Cash | $34 | $52 | $77 | $43 |
| + Debt | $426 | $448 | $464 | $393 |
| Enterprise Value | $1,092 | $1,340 | $1,363 | $1,269 |
| Revenue | $205 | $181 | $164 | $135 |
| % Growth | 13.4% | 10.5% | 21.3% | – |
| Gross Profit | $195 | $171 | $153 | $104 |
| % Margin | 95.1% | 94.3% | 93.5% | 77.4% |
| EBITDA | $114 | $101 | $89 | $89 |
| % Margin | 55.5% | 55.8% | 54.4% | 66.2% |
| Net Income | $36 | $36 | $33 | $45 |
| % Margin | 17.5% | 20% | 20% | 33.6% |
| EPS Diluted | 0.17 | 0.17 | 0.15 | 0.21 |
| % Growth | 0% | 13.3% | -28.6% | – |
| Operating Cash Flow | $101 | $6 | $99 | $42 |
| Capital Expenditures | -$81 | -$88 | -$87 | -$44 |
| Free Cash Flow | $20 | -$81 | $12 | -$2 |